129 related articles for article (PubMed ID: 24010883)
1. Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women.
Cheung E; Kung AW; Tan KC
Clin Endocrinol (Oxf); 2014 Feb; 80(2):200-7. PubMed ID: 24010883
[TBL] [Abstract][Full Text] [Related]
2. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.
Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S
Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726
[TBL] [Abstract][Full Text] [Related]
3. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
Bolland MJ; Grey A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581
[TBL] [Abstract][Full Text] [Related]
4. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.
Liu SY; Huang M; Chen R; Ding N; Liu H; Xie ZJ; Sheng ZF; Luo BH; Ou YN
Endocrine; 2019 Jul; 65(1):200-206. PubMed ID: 31111436
[TBL] [Abstract][Full Text] [Related]
5. A comparison of case-finding strategies in the UK for the management of hip fractures.
Johansson H; Kanis JA; Oden A; Compston J; McCloskey E
Osteoporos Int; 2012 Mar; 23(3):907-15. PubMed ID: 22234810
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the NOF and NOGG guidelines for spinal radiographic examination in postmenopausal Chinese women.
Chen R; Liu S; Huang M; Ding N; Wang Q; Xie Z; Liu H; Sheng Z; Ou Y
Arch Osteoporos; 2021 Jan; 16(1):5. PubMed ID: 33399996
[TBL] [Abstract][Full Text] [Related]
7. Impact of FRAX-based osteoporosis intervention using real world data.
Goldshtein I; Ish-Shalom S; Leshno M
Bone; 2017 Oct; 103():318-324. PubMed ID: 28778597
[TBL] [Abstract][Full Text] [Related]
8. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.
Cheung EY; Bow CH; Cheung CL; Soong C; Yeung S; Loong C; Kung A
Osteoporos Int; 2012 Mar; 23(3):871-8. PubMed ID: 21562875
[TBL] [Abstract][Full Text] [Related]
9. Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
Kyriakos G; Vidal-Casariego A; Fernández-Martínez MN; Blanco-Suárez MD; Ballesteros-Pomar MD; Cano-Rodríguez I
J Clin Densitom; 2015; 18(4):533-8. PubMed ID: 26343823
[TBL] [Abstract][Full Text] [Related]
10. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
[TBL] [Abstract][Full Text] [Related]
11. Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.
Cheung E; Cheung CL; Kung AW; Tan KC
Osteoporos Int; 2014 Mar; 25(3):1017-23. PubMed ID: 24196720
[TBL] [Abstract][Full Text] [Related]
12. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice.
Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Calleja-Fernández A; Ávila-Turcios D; Urosa-Maggi JA; Ballesteros-Pomar MD; Cano-Rodríguez I
Reumatol Clin; 2017; 13(5):258-263. PubMed ID: 27373582
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
Silva DMW; Borba VZC; Kanis JA
Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
[TBL] [Abstract][Full Text] [Related]
14. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
[TBL] [Abstract][Full Text] [Related]
15. The importance of morphometric radiographic vertebral assessment for the detection of patients who need pharmacological treatment of osteoporosis among postmenopausal diabetic Korean women.
Choi YJ; Yang SO; Shin CS; Chung YS
Osteoporos Int; 2012 Aug; 23(8):2099-2105. PubMed ID: 21975560
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of US and Canadian Osteoporosis Screening and Treatment Strategies in Postmenopausal Women.
Crandall CJ; Larson J; Manson JE; Cauley JA; LaCroix AZ; Wactawski-Wende J; Datta M; Sattari M; Schousboe JT; Leslie WD; Ensrud KE
J Bone Miner Res; 2019 Apr; 34(4):607-615. PubMed ID: 30536628
[TBL] [Abstract][Full Text] [Related]
17. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
[TBL] [Abstract][Full Text] [Related]
18. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA
Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128
[TBL] [Abstract][Full Text] [Related]
19. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study.
Berry SD; Kiel DP; Donaldson MG; Cummings SR; Kanis JA; Johansson H; Samelson EJ
Osteoporos Int; 2010 Jan; 21(1):53-60. PubMed ID: 19937426
[TBL] [Abstract][Full Text] [Related]
20. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
